IS8138A - Gaboxadól til meðhöndlunar á þunglyndi og öðrum geðrænum truflunum - Google Patents

Gaboxadól til meðhöndlunar á þunglyndi og öðrum geðrænum truflunum

Info

Publication number
IS8138A
IS8138A IS8138A IS8138A IS8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A IS 8138 A IS8138 A IS 8138A
Authority
IS
Iceland
Prior art keywords
gaboxadol
depression
treatment
psychiatric disorders
psychiatric
Prior art date
Application number
IS8138A
Other languages
English (en)
Icelandic (is)
Inventor
Sanchez Connie
Ebert Bjarke
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8138(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2004/000459 external-priority patent/WO2004112786A2/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS8138A publication Critical patent/IS8138A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8138A 2003-06-25 2005-11-21 Gaboxadól til meðhöndlunar á þunglyndi og öðrum geðrænum truflunum IS8138A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25
DKPA200400016 2004-01-07
PCT/DK2004/000459 WO2004112786A2 (en) 2003-06-25 2004-06-25 Gaboxadol for treating depression and other affective disorders

Publications (1)

Publication Number Publication Date
IS8138A true IS8138A (is) 2005-11-21

Family

ID=58707228

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8138A IS8138A (is) 2003-06-25 2005-11-21 Gaboxadól til meðhöndlunar á þunglyndi og öðrum geðrænum truflunum

Country Status (10)

Country Link
KR (1) KR20060025192A (es)
AR (1) AR047550A1 (es)
CA (2) CA2692334A1 (es)
CL (2) CL2004001607A1 (es)
EA (1) EA200600101A1 (es)
IS (1) IS8138A (es)
ME (2) ME00030B (es)
NO (1) NO20060229L (es)
RS (1) RS20050911A (es)
TW (1) TW200509918A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020106927A1 (en) 2018-11-21 2020-05-28 Certego Therapeutics Gaboxadol for reducing risk of suicide and rapid relief of depression
IL298334A (en) 2020-05-20 2023-01-01 Certego Therapeutics Inc A canceled gaboxadol ring and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
CL2010000166A1 (es) 2010-07-02
CA2529805A1 (en) 2004-12-29
NO20060229L (no) 2006-01-16
TW200509918A (en) 2005-03-16
RS20050911A (en) 2007-08-03
MEP1908A (xx) 2010-02-10
CA2692334A1 (en) 2004-12-29
AR047550A1 (es) 2006-01-25
EA200600101A1 (ru) 2006-06-30
CL2004001607A1 (es) 2005-05-27
ME00030B (me) 2010-06-10
KR20060025192A (ko) 2006-03-20

Similar Documents

Publication Publication Date Title
IS8451A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
IS8410A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
IS7977A (is) Samsetningar og aðferð til samsettra meðferðar
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DK1660057T3 (da) Kombinationsterapi til behandling af neovaskulære øjenlidelser
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1641822T3 (da) Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
IS2722B (is) 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
IS8497A (is) Aðferðir og hvarfefni til að meðhöndla bólgusjúkdóma
HK1203216A1 (en) Materials and methods for treating disorders of the ear
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
NO20045554L (no) Fremgangsmate for behandling av diabetes
NO20055450D0 (no) Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon
NO20052859D0 (no) Fremgangsmate for fremstilling av resperidon og intermediater derav
NO20052814D0 (no) Cytomodulerende peptider for behandling av interstitielle cystitt
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
DK1589973T4 (da) Formulering og fremgangsmåder til behandling af thrombocytæmi
DK1599469T3 (da) Tetrazolderivater og fremgangsmåder til behandling af metabolismerelaterede forstyrrelser dermed